celastrol has been researched along with navitoclax in 1 studies
Studies (celastrol) | Trials (celastrol) | Recent Studies (post-2010) (celastrol) | Studies (navitoclax) | Trials (navitoclax) | Recent Studies (post-2010) (navitoclax) |
---|---|---|---|---|---|
885 | 1 | 741 | 429 | 15 | 401 |
Protein | Taxonomy | celastrol (IC50) | navitoclax (IC50) |
---|---|---|---|
Bcl-2-like protein 11 | Homo sapiens (human) | 0.0043 | |
Apoptosis regulator Bcl-2 | Homo sapiens (human) | 0.0091 | |
Bcl-2-like protein 1 | Homo sapiens (human) | 0.0168 | |
Aspartyl/asparaginyl beta-hydroxylase | Homo sapiens (human) | 1.0925 | |
Bcl-2-like protein 2 | Homo sapiens (human) | 0.07 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kang, J; Li, Q; Liu, C; Wang, R; Xu, M; Zhou, M | 1 |
1 other study(ies) available for celastrol and navitoclax
Article | Year |
---|---|
Screening of Small-Molecule Inhibitors of Protein-Protein Interaction with Capillary Electrophoresis Frontal Analysis.
Topics: Aniline Compounds; Apoptosis; bcl-X Protein; BH3 Interacting Domain Death Agonist Protein; Binding, Competitive; Electrophoresis, Capillary; Fluoresceins; HT29 Cells; Humans; Kinetics; Ligands; Pentacyclic Triterpenes; Protein Interaction Domains and Motifs; Small Molecule Libraries; Sulfonamides; Triterpenes | 2016 |